HUP0202630A2 - Meiózisra ható anyagokat tartalmazó készítmények - Google Patents

Meiózisra ható anyagokat tartalmazó készítmények

Info

Publication number
HUP0202630A2
HUP0202630A2 HU0202630A HUP0202630A HUP0202630A2 HU P0202630 A2 HUP0202630 A2 HU P0202630A2 HU 0202630 A HU0202630 A HU 0202630A HU P0202630 A HUP0202630 A HU P0202630A HU P0202630 A2 HUP0202630 A2 HU P0202630A2
Authority
HU
Hungary
Prior art keywords
compositions containing
activating substance
meiosis activating
meiosis
substance
Prior art date
Application number
HU0202630A
Other languages
English (en)
Inventor
Tina Meinertz Andersen
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of HUP0202630A2 publication Critical patent/HUP0202630A2/hu
Publication of HUP0202630A3 publication Critical patent/HUP0202630A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Abstract

A jelen találmány az in vitro megtermékenyítéssel kapcsolatbanhasználható szilárd termékekre vonatkozik, melyek meiózisra hatóanyagokat tartalmaznak. Ó
HU0202630A 1999-09-16 2000-09-11 Compositions containing meiosis activating substance HUP0202630A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901308 1999-09-16
PCT/DK2000/000500 WO2001019354A2 (en) 1999-09-16 2000-09-11 Composition for ivf

Publications (2)

Publication Number Publication Date
HUP0202630A2 true HUP0202630A2 (hu) 2002-12-28
HUP0202630A3 HUP0202630A3 (en) 2004-06-28

Family

ID=8103409

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202630A HUP0202630A3 (en) 1999-09-16 2000-09-11 Compositions containing meiosis activating substance

Country Status (21)

Country Link
US (1) US6844313B1 (hu)
EP (1) EP1216059B1 (hu)
JP (1) JP2003509365A (hu)
KR (1) KR100757909B1 (hu)
CN (1) CN1222319C (hu)
AT (1) ATE306942T1 (hu)
AU (1) AU781994B2 (hu)
BR (1) BR0014058A (hu)
CA (1) CA2382908A1 (hu)
CZ (1) CZ2002591A3 (hu)
DE (1) DE60023324T2 (hu)
ES (1) ES2252048T3 (hu)
HU (1) HUP0202630A3 (hu)
IL (1) IL148234A0 (hu)
MX (1) MXPA02002439A (hu)
NO (1) NO323694B1 (hu)
PL (1) PL202224B1 (hu)
RU (1) RU2263516C2 (hu)
UA (1) UA78183C2 (hu)
WO (1) WO2001019354A2 (hu)
ZA (1) ZA200201383B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020013505A (ko) * 1999-02-26 2002-02-20 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열활성 스테롤에 의한 착상율의 증가
DE60023324T2 (de) 1999-09-16 2006-07-20 Novo Nordisk A/S Zusammensetzung zur in-vitro befruchtung
CA2399036A1 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
US6988613B2 (en) 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4175074A (en) 1976-08-23 1979-11-20 Deshmukh Arvind D Serum-soluble cholesterol compounds and method for their preparation
US4751219A (en) 1985-02-05 1988-06-14 Nederlandse Centrale Organisatie Voor Toegepast-Natuur-Wetenschappelijk Onderzoek Synthetic glycolipides, a process for the preparation thereof and several uses for these synthetic glycolipides
WO1990003429A1 (en) * 1988-09-23 1990-04-05 Cetus Corporation Lipid microemulsions for culture media
DE4221880A1 (de) 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen
JPH08503950A (ja) * 1992-12-02 1996-04-30 アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド 徐放性成長ホルモン含有マイクロスフェア
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
US6281015B1 (en) * 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
WO1996027658A1 (en) 1995-03-06 1996-09-12 Novo Nordisk A/S Stimulation of meiosis
RU2182909C2 (ru) 1995-06-23 2002-05-27 Ново Нордиск А/С Стероиды, способ регулирования мейоза
GB9625175D0 (en) * 1996-12-04 1997-01-22 Medi Cult As Serum-free cell culture media
HUP9904616A3 (en) * 1996-12-20 2001-02-28 Novo Nordisk As Meiosis regulating cholestane-derivatives
EP0988312B1 (en) 1997-06-04 2002-04-03 Akzo Nobel N.V. 17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
HUP9701554D0 (en) 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
WO1999061010A2 (en) 1998-05-26 1999-12-02 Schering Aktiengesellschaft Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound
KR20020013505A (ko) * 1999-02-26 2002-02-20 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열활성 스테롤에 의한 착상율의 증가
DE60023324T2 (de) 1999-09-16 2006-07-20 Novo Nordisk A/S Zusammensetzung zur in-vitro befruchtung

Also Published As

Publication number Publication date
NO323694B1 (no) 2007-06-25
JP2003509365A (ja) 2003-03-11
ATE306942T1 (de) 2005-11-15
DE60023324D1 (de) 2005-11-24
CZ2002591A3 (cs) 2002-08-14
PL353968A1 (en) 2003-12-15
NO20021309L (no) 2002-03-15
BR0014058A (pt) 2004-03-30
ZA200201383B (en) 2002-11-27
AU6985000A (en) 2001-04-17
US6844313B1 (en) 2005-01-18
KR100757909B1 (ko) 2007-09-11
CN1373675A (zh) 2002-10-09
NO20021309D0 (no) 2002-03-15
WO2001019354A3 (en) 2001-06-14
HUP0202630A3 (en) 2004-06-28
EP1216059B1 (en) 2005-10-19
WO2001019354A2 (en) 2001-03-22
ES2252048T3 (es) 2006-05-16
CA2382908A1 (en) 2001-03-22
EP1216059A2 (en) 2002-06-26
RU2263516C2 (ru) 2005-11-10
UA78183C2 (en) 2007-03-15
KR20020032593A (ko) 2002-05-03
MXPA02002439A (es) 2002-07-30
IL148234A0 (en) 2002-09-12
PL202224B1 (pl) 2009-06-30
DE60023324T2 (de) 2006-07-20
CN1222319C (zh) 2005-10-12
AU781994B2 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
ATE295347T1 (de) Stoffe und zusammensetzungen für die verabreichung aktiver substanzen
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
MY125651A (en) Eplerenone compositions
MY124214A (en) Compositions for promoting crowth
MEP39108A (en) Pharmaceutical composition
BRPI0115953B8 (pt) complexos de derivados de fosfato
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
MXPA05010607A (es) Composiciones de distribucion de farmacos de ester de alfa-hidroxiacido y metodos de uso.
HUP0200157A2 (hu) A terméketlenség kezelése
ATE252375T1 (de) Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
IL139318A (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
HUP0202630A2 (hu) Meiózisra ható anyagokat tartalmazó készítmények
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
PL353209A1 (en) Paracetamol and drotaverine containing composition
TR200103126T2 (tr) Yapısal titremenin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri
GB9818445D0 (en) Medicaments
ATE357246T1 (de) Pharmazeutische träger zusammensetzung für produkte auf basis von papain
HN1999000007A (es) Nuevas composiciones y metodos para uso en el cultivo de bananos y platanos.
AU8987198A (en) Product comprising at least a double stranded rna combined with at least a 6-benzyluracil derivative
MD20040296A (ro) Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activ

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished